Endogenous Ligand-Derived Ligand Discovery Services

* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.

Many of the most selective interactions in biology do not come from synthetic inhibitor chemistry—they come from the body's own chemical vocabulary. Hormones, metabolites, cofactors, enzyme substrates, neurotransmitters, and lipid mediators bind human proteins with recognition that has been refined by evolution. An endogenous ligand-derived warhead takes one of these native binders and converts it into a degradation-ready targeting ligand: a fragment that retains endogenous recognition while carrying the exit vectors and, where needed, the covalent functionality required for degrader assembly.

BOC Sciences provides endogenous ligand-derived warhead discovery services for targeted protein degradation, covering target and ligand feasibility assessment, endogenous ligand identification and hit prioritization, scaffold derivatization and exit vector design, warhead analogue synthesis, and target-binding validation. By integrating chemoinformatic ligand mining, biophysical and computational screening, structural analysis, and medicinal chemistry, we turn nature's own binders into warheads your degrader program can build on.

Request a Consultation Explore Services
Overview

What Are Endogenous Ligand-Derived Warheads in Targeted Protein Degradation?

An endogenous ligand-derived warhead is a target-engaging ligand built from a molecule that already exists in human biology—an estrogen-derived scaffold for nuclear receptor recognition, a retinoid framework for retinoid-signaling proteins, an adenine nucleotide core for nucleotide-binding pockets, or electrophilic motifs inspired by reactive metabolites such as itaconate-like and prostaglandin-like species. Because the starting recognition element is native, the resulting warhead often inherits a biologically prevalidated binding mode, a compact molecular architecture, and selectivity driven by endogenous binding principles rather than by generic electrophile reactivity.

For degradation research, this starting point solves a recurring problem: many attractive degradation targets have no potent inhibitor available to convert into a warhead. Endogenous ligands offer an alternative entry point into these proteins, and they can also open new recruiter directions, since endogenous scaffolds that engage components of the degradation machinery can be developed into E3-recruiting warheads rather than target warheads alone.

In both cases, the design discipline is the same: preserve what evolution optimized—the recognition—while engineering what a degrader needs—exit vectors, controllable reactivity, and linker compatibility. Every service module at BOC Sciences is organized around that balance.

Services

BOC Sciences Endogenous Ligand-Derived Warhead Discovery Services for PROTAC Development

BOC Sciences delivers endogenous ligand-derived warhead discovery as an integrated workflow, from judging whether a target can realistically be engaged by its native chemistry to delivering synthesized warhead analogues with confirmed target binding. Our broader ligand design for target protein capabilities provide the foundation, and every endogenous ligand project is planned around how the final warhead will behave inside a degrader architecture.

Gene Therapy

Target and Endogenous Ligand Feasibility Assessment

We help determine whether an endogenous ligand strategy is realistic for your target, through:

  • Target and binding-site review service: analysis of the target's ligandability, subcellular localization, and degradation rationale before ligand mining begins.
  • Endogenous ligand landscape service: mapping of the hormones, metabolites, cofactors, substrates, and lipid mediators that natively engage the target or its binding pocket, including local pKa and nucleophile context when covalent engagement is considered.
  • Feasibility recommendation service: a written go/no-go assessment naming the most promising ligand class, expected binding mode, and design risks before any chemistry is committed.
Gene Therapy

Endogenous Ligand Identification and Hit Prioritization

BOC Sciences converts a broad space of endogenous chemistry into a short list of testable starting points through:

  • Ligand mining service: literature- and database-driven mining of endogenous binders, substrate analogs, and metabolite species relevant to your target.
  • Screening and docking service: biophysical screening of endogenous and endogenous-inspired compound sets, complemented by virtual screening and molecular docking against the target binding pocket.
  • Hit prioritization service: ranking of candidates on affinity, selectivity, availability of structural data, and tolerance to derivatization, so chemistry effort is spent on ligands that can actually become warheads.
Gene Therapy

Ligand Scaffold Derivatization and Exit Vector Design

We prepare a confirmed endogenous binder for degrader construction through:

  • Modification-tolerance mapping service: evaluation of which positions on the endogenous scaffold tolerate substitution without disrupting native recognition, using structural data and in silico conformational analysis.
  • Exit vector design service: identification of solvent-exposed attachment points that preserve binding geometry, supported by our linker binding site selection and design services.
  • Focused analog design service: design of derivatization-ready analog series that vary attachment position, linker projection angle, and, where appropriate, covalent functionality.
Gene Therapy

Warhead Analogue Synthesis and Target-Binding Validation

BOC Sciences delivers warhead candidates together with evidence that the endogenous recognition survived derivatization, using:

  • Analogue synthesis service: custom synthesis of warhead analogues from endogenous scaffolds, including stereochemically defined hormone- and lipid-derived series.
  • Binding validation service: quantitative confirmation of retained target engagement by binding affinity measurement across orthogonal biophysical formats.
  • Structural confirmation service: protein-ligand structure analysis or NMR-based evidence showing that the derivatized warhead binds in the intended pose relative to the parent ligand.
Ligand Classes

Endogenous Ligand Classes We Explore for Warhead Discovery

Endogenous chemistry is not a single category but a set of distinct ligand families, and each family brings different design opportunities for degradation research. BOC Sciences explores the following classes in parallel and selects the starting point by the biology of your target rather than by scaffold availability. Our warhead library can also provide a starting point for exploring relevant warhead structures and chemical building blocks.

Ligand Class Representative Endogenous Ligands Warhead Design Opportunity
Hormones, neurotransmitters, and receptor ligands Steroid hormones, retinoids, thyroid hormone, catecholamines, serotonin-type ligands Target warheads for receptor, transporter, and channel degradation; recruiter candidates via native receptor engagement
Endogenous metabolites and cofactors Itaconate-like electrophiles, NAD+, ATP, folate species, glutathione-derived motifs Substrate-competitive warheads for conserved metabolite-binding pockets; tunable electrophilic motifs for covalent engagement
Enzyme substrates and product-derived ligands Acyl-lysine-like species, coenzyme adducts, nucleotide substrates, peptide substrates Active-site-directed warheads for enzymes that lack inhibitor chemical matter
Endogenous peptides and lipid mediators Neuropeptides, endocannabinoids, prostaglandins, fatty acid mediators Warheads for GPCR, lipid-binding protein, and membrane protein degradation research

Hormones, Neurotransmitters, and Receptor Ligands

Steroid hormones, retinoids, thyroid hormone, catecholamines, and serotonin-type ligands bind nuclear receptors, GPCRs, and transporters with high intrinsic selectivity. This makes them efficient starting points for targets whose pockets are difficult to address with generic fragment chemistry. BOC Sciences evaluates:

  • Receptor-orthogonal recognition: whether the native binding mode of the hormone or transmitter can be retained while the scaffold is reshaped for degrader use.
  • Scaffold derivatization positions: ring and side-chain positions on steroid and retinoid frameworks that tolerate linker attachment without disrupting receptor recognition.
  • Recruiter conversion potential: whether the same endogenous scaffold can be repurposed to engage degradation machinery components as an alternative to target-directed use.

Endogenous Metabolites and Cofactors

Metabolites and cofactors occupy conserved protein pockets and include several chemically reactive species, so this class serves both noncovalent and covalent warhead strategies. Representative design strategies include:

  • Substrate-competitive warheads: cofactor- and metabolite-mimetic ligands directed at conserved nucleotide- and metabolite-binding pockets, where the parent molecule defines the recognition geometry.
  • Electrophilic motif exploitation: conversion of naturally electrophilic metabolite scaffolds into controllable cysteine- or lysine-reactive warheads, with electronics adjusted to the reactivity window the target supports.
  • Reactivity containment: steric and electronic tuning so the analogue retains the recognition of the parent metabolite but reacts only within the intended binding context.

Enzyme Substrates and Product-Derived Ligands

For enzymes that lack inhibitor chemical matter, substrates and reaction products are the most direct binding starting points available. BOC Sciences works with:

  • Substrate-inspired ligands: substrate analogs shaped toward the ground-state and transition-state geometries the target enzyme naturally recognizes.
  • Product- and intermediate-derived scaffolds: coenzyme adducts, acyl-enzyme-like structures, and acyl-lysine-like chemotypes adapted for active-site engagement.
  • Active-site covalent conversion: installation of mild electrophiles onto substrate-derived scaffolds when a catalytic nucleophile is positioned for productive covalent engagement.

Endogenous Peptides and Lipid Mediators

Neuropeptides, endocannabinoids, prostaglandins, and fatty acid mediators define shallow, dynamic binding sites on GPCRs, lipid-binding proteins, and membrane-associated targets. Design approaches include:

  • Peptidomimetic warhead conversion: truncation, cyclization, and backbone modification strategies that preserve peptide recognition while improving compatibility with degrader architectures.
  • Lipid mediator scaffold design: head-group- and chain-modified analogs that retain lipid-binding recognition and introduce clean attachment vectors.
  • Membrane-context engagement assessment: evaluation of how the membrane environment and conformational state of the target affect ligand presentation, using in vitro membrane-associated assay formats.

Which Endogenous Ligand Class Fits Your Degradation Target?

Share your target protein and the endogenous chemistry you want to exploit with BOC Sciences. Our team can map the native ligand landscape of your target, compare hormone-, metabolite-, substrate-, peptide-, and lipid-derived strategies, and recommend the warhead class most likely to support productive degradation.

Discuss Your Warhead Strategy

Workflow

Our Workflow for Endogenous Ligand-Derived Warhead Discovery

01

Endogenous Ligand Mining and Target Feasibility Review

We review the target, its structural data, and its native ligand environment, then recommend the endogenous ligand class and the degradation role—target warhead or recruiter candidate—that the program should pursue first.

02

Ligand-Based Screening and Warhead Hit Identification

Candidate endogenous ligands and endogenous-inspired analogue sets are screened biophysically and computationally. Hits are triaged on affinity, selectivity, and tolerance to derivatization, so that only ligands compatible with degrader assembly move forward.

03

Covalent Engagement Validation and Chemoproteomic Confirmation

Where covalent engagement is intended, adduct formation and reversibility are validated by intact-protein mass spectrometry, and chemoproteomic experiments confirm that modification occurs at the intended site within the intended binding context.

04

Structure-Guided Optimization and Degrader Compatibility Assessment

Optimized warheads are delivered with exit-vector options and an assessment of how linker attachment affects endogenous recognition, then move into PROTAC design services for linker assembly and E3 ligand pairing.

Troubleshooting

Design Challenges We Solve in Endogenous Ligand-Derived Warhead Programs

Endogenous ligand-derived warhead development requires converting evolutionarily optimized binders into modular, degrader-ready ligands without losing the recognition that made them attractive. BOC Sciences addresses the most common failure modes through structural analysis, derivatization planning, and systematic validation.

Insufficient Binding Affinity or Target Selectivity

Many endogenous ligands bind their proteins with modest affinity, or engage whole families of related receptors and enzymes, making them weak starting points for selective degradation. BOC Sciences extends potency through structure-guided substituent design, runs family-panel counterscreening to expose selectivity gaps early, and combines endogenous recognition elements with affinity-enhancing features identified through our screening platforms.

Loss of Target Recognition After Ligand Modification

Adding an exit vector or an electrophile to a compact endogenous scaffold can disrupt the hydrogen-bond network and binding pose the parent ligand depends on. BOC Sciences uses molecular dynamics simulation and structural comparison of parent and derivatized ligands to locate tolerant positions, then re-anchors the recognition element before further optimization proceeds.

Limited Linker-Attachment Sites and Unfavorable Exit Vectors

Endogenous scaffolds are small and densely functionalized, so few positions project toward solvent without distorting the binding mode. BOC Sciences evaluates exit vectors across conformational ensembles rather than single static structures, and designs spacer, ring-expansion, and bioisosteric strategies that relocate the attachment point while preserving the recognition geometry.

Poor Physicochemical Properties and Cellular Target Engagement

Hormone- and lipid-derived scaffolds are often highly lipophilic, whereas metabolite-derived scaffolds can be too polar; either extreme can limit intracellular availability of the final degrader. BOC Sciences profiles solubility, permeability, and cellular target engagement early in the program, and balances endogenous recognition against developability so the warhead performs inside a whole molecule rather than only in a biochemical assay.

Struggling to Convert Endogenous Biology into a Workable Warhead?

Whether you are facing weak native affinity, recognition loss after derivatization, unfavorable exit vectors, or poor cellular engagement, BOC Sciences can help diagnose the limiting factor and define a practical optimization path for your endogenous ligand-derived warhead program.

Discuss Your Challenges

Applications

Target Classes and Research Applications of Endogenous Ligand-Derived Warheads

Nuclear Receptor-Targeting Warhead Design

Nuclear receptors are among the most established targets for endogenous ligand-derived PROTAC development because their natural hormones provide well-characterized ligand-binding scaffolds. Early proof-of-concept studies demonstrated that dihydrotestosterone (DHT)- and 17β-estradiol (E2)-based PROTACs could induce androgen receptor (AR) and estrogen receptor alpha (ERα) degradation, respectively. Subsequent research further explored estradiol derivatization at the 11β-position, producing ERα-targeting PROTAC 15b with a reported DC50 of 67 nM. These studies demonstrate how natural hormone scaffolds can be modified for receptor recognition and degrader construction (Oncogene, 2008; J. Steroid Biochem. Mol. Biol., 2022).

GPCR-Targeting Warhead Design

G protein-coupled receptors (GPCRs) recognize diverse endogenous signaling molecules, including hormones, neurotransmitters, and peptides, providing opportunities for developing receptor-targeting warheads. A notable proof of concept involves the G protein-coupled estrogen receptor (GPER), which was targeted using two estradiol-derived PROTACs, UI-EP001 and UI-EP002. Both compounds demonstrated degradation of GPER as well as ERα and ERβ, with the estradiol-derived targeting domain supporting receptor recognition. This study provides direct evidence that an endogenous hormone-derived scaffold can be adapted to target both nuclear and membrane-associated estrogen receptors (Mol. Pharmaceutics, 2021).

Enzyme-Targeting Warhead Design

Enzymes recognize endogenous substrates and cofactors through specific catalytic or regulatory binding regions, providing potential starting points for ligand-derived warhead discovery. ATP-binding kinases, S-adenosylmethionine (SAM)-dependent methyltransferases, UDP-sugar-dependent glycosyltransferases, and peptide-recognizing proteases represent relevant target classes for this strategy. Their endogenous substrates or cofactors can guide scaffold identification and structure-based derivatization. However, these approaches remain target-dependent research opportunities rather than established examples of endogenous substrate-derived PROTACs. BOC Sciences can help investigate substrate-binding interactions, identify suitable modification positions, and evaluate whether derived ligands can retain target recognition after linker attachment.

Transporter and Ion Channel-Targeting Warhead Design

Transporters and ligand-gated ion channels recognize endogenous substrates or signaling molecules through specialized binding sites, offering additional opportunities for target-binding warhead discovery. Potential starting scaffolds include serotonin, dopamine, norepinephrine, glucose, and endogenous neurotransmitter ligands. Research has demonstrated that SLC transporter proteins can undergo ligand-induced degradation using heterobifunctional compounds, supporting the feasibility of targeting multi-pass membrane proteins. However, this finding does not establish an endogenous substrate-derived warhead example. Further exploration is needed to determine whether natural substrate scaffolds can be modified while preserving transporter or channel recognition (Cell Chem. Biol., 2020).

Do You Have a Known Endogenous Ligand for Application-Driven PROTAC Development?

Whether you already have an endogenous ligand or need to identify a suitable one for your target, BOC Sciences can help evaluate ligand feasibility, explore suitable scaffolds, and optimize ligand structures according to your specific research applications. Share your target protein and development objectives with our experts to identify promising ligand candidates and streamline your PROTAC discovery process, saving valuable project time and resources.

Discuss Your Application

Why Us

Why Choose BOC Sciences for Endogenous Ligand-Derived Warhead Discovery?

Integrated Endogenous Ligand Knowledge and Chemoproteomic Discovery

Ligand mining, biophysical screening, chemoproteomic target confirmation, and structural analysis run inside one team, so an endogenous ligand hypothesis and its experimental validation are never separated by a handoff between vendors.

Multi-Class Endogenous Scaffold Conversion Capability

We work across hormone, metabolite, cofactor, substrate, peptide, and lipid chemotypes in parallel, so the warhead is chosen by the biology of your target, not by the scaffold class we happen to hold.

Reactivity- and Selectivity-Controlled Warhead Design

Where covalent engagement is intended, electrophile electronics, sterics, and adduct lifetime are tuned deliberately, and every candidate is characterized for target selectivity against competing nucleophiles and related proteins.

Degrader-Oriented Warhead Delivery and Degradation Evaluation

Warheads are designed with exit vectors and ternary-complex feasibility in mind, and can be carried through conjugation and degradation ability assay evaluation from the same compound batch, closing the loop between warhead design and degradation outcome.

Frequently Asked Questions (FAQ)

Frequently Asked Questions

Still have questions?

Contact Us

An endogenous ligand-derived warhead is a target-binding moiety developed from a naturally occurring molecule that interacts with a specific protein. Common starting points include hormones, neurotransmitters, metabolites, and enzyme substrates. In PROTAC development, these natural scaffolds are chemically modified to introduce suitable linker attachment positions while retaining essential protein recognition interactions. Unlike an E3 ligase ligand, this component binds the protein of interest (POI) and helps recruit it into a productive ternary complex. Most endogenous ligand-derived warheads rely on non-covalent recognition rather than covalent bond formation.

Several endogenous ligand classes can provide starting points for warhead discovery, depending on the target protein and its natural binding mechanism. These include steroid hormones such as estradiol and testosterone, neurotransmitters such as dopamine and serotonin, metabolic cofactors such as ATP and NAD, enzyme substrates, endogenous peptides, and lipid mediators. Each class presents different opportunities for structural modification. BOC Sciences can help evaluate these ligand sources, identify promising molecular scaffolds, and prioritize candidates according to target recognition, chemical accessibility, and their potential for PROTAC construction.

Endogenous ligand identification begins with understanding the target protein's biological function, natural binding partners, and ligand-recognition mechanisms. Researchers can investigate published ligand information, biochemical pathways, protein structures, and available ligand databases to identify potential starting molecules. Computational methods, including molecular docking and virtual screening, can then prioritize candidates according to binding-site compatibility and interaction patterns. BOC Sciences integrates target assessment, ligand mining, computational screening, and experimental binding characterization to help identify and validate suitable ligand candidates, including targets with limited established small-molecule starting points.

Native endogenous ligands are not always suitable for direct incorporation into PROTAC molecules. Although they may recognize their target proteins naturally, their molecular structures may lack accessible positions for linker attachment or contain functional groups essential for binding. Chemical derivatization is therefore often necessary to introduce an appropriate exit vector while preserving important ligand-protein interactions. BOC Sciences evaluates ligand structures, binding orientations, and modification tolerance to identify suitable attachment positions. Candidate derivatives can then undergo synthesis and binding validation to determine whether they remain appropriate for further degrader development.

Warhead optimization is an important part of PROTAC development, but strong binary binding alone does not guarantee efficient protein degradation. The modified ligand must retain target recognition while supporting productive ternary complex formation with the selected E3 ligase. Linker attachment position, molecular orientation, steric compatibility, and overall physicochemical properties can all influence degradation performance. BOC Sciences can integrate warhead optimization with linker design, PROTAC synthesis, and experimental degradation evaluation to investigate how structural modifications affect target engagement and degradation activity.

* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.

  • Verification code
Inquiry Basket